Metraipolis › archive › dc_dfe65cc42a36

Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40869350
DOI
10.3390/ijms26168029
License (as archived)
solo-consultazione
Archived
2026-11-10T11:54:34.571Z
SHA-256 of the archived text
0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c
Stable URL of this page
https://metraipolis.com/documento/dc_dfe65cc42a36

How to cite

Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350 — Europe PMC (en), https://europepmc.org/article/MED/40869350 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfe65cc42a36 (Metraipolis archive dc_dfe65cc42a36, sha256 0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c)
BibTeX
@misc{dcdfe65cc42a36,
  title = {Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40869350},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfe65cc42a36; sha256 0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869350. Agents can read the archived copy with the MCP tool read_document.